The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

Helping an older adult stay consistent with breathing treatments can feel like a full-time job - especially when COPD, asthma ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist (LAMA) or a Leukotriene Receptor Antagonist (LTRA) on top of a moderate-dose ...

A monthly injection could enable severe asthma patients to stop taking daily steroid tablets without affecting their symptoms, a new trial has found. The drug, Tezepelumab (also known as Tezspir and ...

Treatments for allergies and asthma such as epinephrine pens and inhalers can be life saving…and cost prohibitive. These devices can be expensive, and often, patients need more than one, multiplying ...

Amneal has received tentative approval from the Food and Drug Administration for an inhalation aerosol to treat asthma. The biopharmaceutical company said the product, called beclomethasone ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Chiesi USA's asthma inhaler ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...

A common asthma medication could be the key to preventing life-threatening reactions to food allergies. That's from a multi-year effort by researchers at Northwestern University in Illinois; they ...

New understanding of a receptor key to allergic responses and anaphylaxis in conditions like asthma could offer a new treatment target for sufferers of a variety of conditions. This the promise of a ...

Asthma severity can be affected by multiple inflammatory pathways, which make it challenging to treat with a “one size fits all” approach. This is why researchers started pursuing precision medicine ...

The latest advances in asthma care combine revolutionary biologics, individualized immunotherapy, and targeted treatments that address specific triggers, ditching the “one-size-fits-all” approach. The ...